14 research outputs found

    Avicennia marina (mangrove) soil amendment changes the fungal community in the rhizosphere and root tissue of mungbean and contributes to control of root-knot nematodes

    Get PDF
    The effect of soil amendment with Avicennia marina (mangrove) on mungbean growth and mungbean infestation with Meloidogyne javanica was determined in greenhouse pot experiments. Galling and final nematode population densities were reduced by all soil amendments with mangrove. To better understand whether nematode suppression by A. marina was caused directly by the release of nematicidal factor(s) into the soil, or was due indirectly to changes in the fungal community, the diversity of the rhizosphere populations of culturable fungi was assessed before organic amendment (day 0), after decomposition but before seed sowing (day 15) and at harvest (day 73). Thirteen out of 20 fungal species were isolated from both A. marina-amended and unamended soils, the most frequent genera being Alternaria, Aspergillus, Fusarium, Penicillium, Trichoderma, Mucor, Myrothecium and Rhizoctonia. The other seven were found only in amended soils. At different times in the course of the experiment amended and unamended soils differed significantly in the fungi isolated from the rhizosphere and/or in the concentrations of A. marina. Trichoderma viride was isolated only from surface-sterilized mungbean roots grown in amended soils, whereas Chaetomium sp. was isolated only from unamended soils

    Future and potential spending on health 2015-40: Development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries

    Get PDF
    Background: The amount of resources, particularly prepaid resources, available for health can affect access to health care and health outcomes. Although health spending tends to increase with economic development, tremendous variation exists among health financing systems. Estimates of future spending can be beneficial for policy makers and planners, and can identify financing gaps. In this study, we estimate future gross domestic product (GDP), all-sector government spending, and health spending disaggregated by source, and we compare expected future spending to potential future spending. Methods: We extracted GDP, government spending in 184 countries from 1980-2015, and health spend data from 1995-2014. We used a series of ensemble models to estimate future GDP, all-sector government spending, development assistance for health, and government, out-of-pocket, and prepaid private health spending through 2040. We used frontier analyses to identify patterns exhibited by the countries that dedicate the most funding to health, and used these frontiers to estimate potential health spending for each low-income or middle-income country. All estimates are inflation and purchasing power adjusted. Findings: We estimated that global spending on health will increase from US9.21trillionin2014to9.21 trillion in 2014 to 24.24 trillion (uncertainty interval [UI] 20.47-29.72) in 2040. We expect per capita health spending to increase fastest in upper-middle-income countries, at 5.3% (UI 4.1-6.8) per year. This growth is driven by continued growth in GDP, government spending, and government health spending. Lower-middle income countries are expected to grow at 4.2% (3.8-4.9). High-income countries are expected to grow at 2.1% (UI 1.8-2.4) and low-income countries are expected to grow at 1.8% (1.0-2.8). Despite this growth, health spending per capita in low-income countries is expected to remain low, at 154(UI133181)percapitain2030and154 (UI 133-181) per capita in 2030 and 195 (157-258) per capita in 2040. Increases in national health spending to reach the level of the countries who spend the most on health, relative to their level of economic development, would mean $321 (157-258) per capita was available for health in 2040 in low-income countries. Interpretation: Health spending is associated with economic development but past trends and relationships suggest that spending will remain variable, and low in some low-resource settings. Policy change could lead to increased health spending, although for the poorest countries external support might remain essential
    corecore